SOURCE: Revolutions Medical Corp.

Revolutions Medical Corp.

September 14, 2009 18:27 ET

Revolutions Medical Details New Product Improvements and Debuts Dynamic Product Demonstration Video

MOUNT PLEASANT, SC--(Marketwire - September 14, 2009) - Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today detailed further the performance and aesthetic improvements to its flagship Rev Vac syringe, and debuted a highly informative product demonstration video. The video will be accessible tonight at

"We will unveil the long-anticipated enhanced design of the Rev Vac safety syringe on our Website ( tonight," stated Company CEO Ron Wheet. "The improvements increase substantially the readability of the fluid levels and the accuracy of the fluid draw. A distinctive color scheme makes the Rev Vac syringe easily identifiable. Simple to read pictograms on each packet insert allow for reduced training needs while improving correct usage. Combined, these feature enhancements dramatically escalate our competitive advantage in the space, and ensure a product that not only costs less, but significantly outperforms many established products.

"And with our new animated demonstration video, we now have an engaging and educational resource that will serve as both an exceptional sales piece and an unparalleled training tool. At time of product launch, we will feature a dynamic multi-media marketing platform that will further set Revolutions Medical apart as the leading safety syringe company."

The Rev Vac safety syringe received FDA 510K clearance earlier this year; this redesign does not impact that clearance.

To be added to the Revolutions Medical investor email list, please email with RMCP in the subject line.

About Revolutions Medical Corporation (

Revolution Medical's products include the Rev Vac safety syringe (FDA Approved), safety blood drawing device and safety IV catheter. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D and automatic segmentation of images.


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact Information